SCHEMBL12475436

SCHEMBL12475436

CONC(=O)c1sc(-c2ccc(Cl)cc2)nc1C(Br)Br

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.52
SMN1; SMN2 Q16637 6/20 0.51
RAB9A P51151 5/20 0.47
NPC1 O15118 3/20 0.47
KDM4E B2RXH2 2/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 7/20 0.46
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TRPM8 Q7Z2W7 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
XDH P47989 1/20 0.43
PTPN11 Q06124 1/20 0.43
ALOX5 P09917 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.41
CASP3 P42574 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12475304 0.83 NPC1 (0.52) GAASMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL12475719 0.82 RAB9A (0.50) GAASMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL12475343 0.82 RAB9A (0.65) GAASMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL12475734 0.80 SMN1; SMN2 (0.51) GAASMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL12475773 0.80 GAA (0.49) GAASMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL12475963 0.80 GAA (0.48) GAASMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL12475648 0.79 SMN1; SMN2 (0.50) GAASMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL12475559 0.79 MAPT (0.48) GAASMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL12475500 0.79 SMN1; SMN2 (0.50) GAASMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL12475713 0.78 TRPM8 (0.70) GAASMN1; SMN2RAB9ANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012109573-A1 SUBSTITUTED THIAZOLES FOR USE AS ANTIVIRAL AGENTS PURDUE RESEARCH FOUNDATION (US) 2012-08-16 WO disclosed